Maternal obesity increases the risk of abnormal fetal growth, but the underlying mechanisms remain unclear. Because steroid hormones regulate fetal growth, and both pregnancy and obesity markedly alter circadian biology, we hypothesized that maternal obesity disrupts the normal rhythmic profiles of steroid hormones in rat pregnancy. Obesity was established by cafeteria (CAF) feeding for 8 wk prior to mating and throughout pregnancy. Control (CON) animals had ad libitum access to chow. Daily profiles of plasma corticosterone, 11-dehydrocorticosterone, progesterone, and testosterone were measured at Days 15 and 21 of gestation (term ¼ 23 days) in maternal (both days) and fetal (Day 21) plasma. CAF mothers exhibited increased adiposity relative to CON and showed fetal and placental growth restriction. There was no change, however, in total fetal or placental mass due to slightly larger litter sizes in CAF. Nocturnal declines in progesterone were observed in maternal (39% lower) and fetal (45% lower) plasma in CON animals, but these were absent in CAF animals. CAF mothers were hyperlipidemic at both days of gestation, but this effect was isolated to the dark period at Day 21. CAF maternal testosterone was slightly lower at Day 15 (8%) but increased above CON by Day 21 (16%). Despite elevated maternal testosterone, male fetal testosterone was suppressed by obesity on Day 21. Neither maternal nor fetal glucocorticoid profiles were affected by obesity. In conclusion, obesity disrupts rhythmic profiles of maternal and fetal progesterone, preventing the normal nocturnal decline. Obesity subtly changed testosterone profiles but did not alter maternal and fetal glucocorticoids.
INTRODUCTION
Maternal obesity is recognized as a significant risk factor for a range of pregnancy complications, including preeclampsia [1, 2] and abnormal fetal growth (either macrosomia or growth restriction) [3] . Moreover, animal and human studies show that offspring born to obese pregnancies carry a greater risk for cardiometabolic complications in later life [4, 5] . Although the links between maternal obesity, fetal growth, and developmental programming are well established, the underlying mechanisms remain poorly understood.
Fetal and placental growth are both strongly influenced by steroid hormones, including glucocorticoids and progesterone. In rodents, maternal glucocorticoids potently inhibit fetal and placental growth [6] [7] [8] and lead to adverse programming outcomes in offspring [9, 10] . Similarly, elevated testosterone can reduce fetal growth in the rat, in part via suppression of placental amino acid transport [11] . In contrast, progesterone supports placental growth and function [12, 13] , possibly by impeding the action of glucocorticoids [14] . Glucocorticoid levels are regulated by the hypothalamic-pituitary-adrenal (HPA) axis, and recent evidence suggests that activity of this axis in pregnancy is altered by maternal obesity. For example, there are reports of both reduced [15, 16] and increased [17] maternal HPA activity in obese women, and in each of these studies the effects were dependent on time of day. Moreover, maternal progesterone is reduced in severely obese women [16] , whereas in rodent models both corticosterone [18, 19] and progesterone [20, 21] are elevated in obese pregnancy. Although some of these inconsistencies likely reflect species differences, the timing of sample collection may also be important because circadian variation is a key feature of the HPA axis [22] . Moreover, maternal and fetal progesterone levels can vary in a circadian fashion in humans [23] and nonhuman primates [24] , and we recently observed circadian variation in maternal progesterone in the pregnant mouse [25] . Whether such variation occurs in rodent pregnancy and is affected by obesity is unknown. Importantly, previous studies in nonpregnant mice show that obesity disrupts various aspects of circadian biology [26, 27] . Therefore, we hypothesized that maternal obesity in pregnancy disturbs the daily rhythmic profiles of glucocorticoids, progesterone, and testosterone in the mother and fetus. Maternal obesity was established in a rat model prior to pregnancy by cafeteria feeding [28] , and blood samples were obtained during Days 15-16 and 21-22 of gestation (term ¼ 23 days), thus spanning the period of maximal fetal growth. The impact of obesity on fetal and placental growth trajectories was also measured across the two sampling days.
MATERIALS AND METHODS

Animals and Diets
All animal work was approved by the Animal Ethics Committee of The University of Western Australia. Nulliparous female albino Wistar rats were obtained at 3 wk of age from the Animal Resources Centre (Murdoch, Australia) and were housed at the Preclinical Facility at The University of Western Australia. Animals were kept three per cage and maintained under a constant 12L:12D cycle at an ambient temperature of 228C. After 1 wk of acclimatization, animals were separated into control (CON) and cafeteria (CAF) groups. Both groups were allowed ad libitum access to standard rodent chow (14 KJ/g total energy; 12% energy as fat, 23% protein, and 65% carbohydrate; Specialty Feeds), and CAF animals were supplemented with a selection of four human junk food items each day (hot dogs, cookies, etc.). Cafeteria items were offered in excess to be essentially ad libitum, and items were rotated each day to maintain novelty. The CAF diet provided an overall average total energy of 16.4 KJ/g; 47% energy as fat, 8% as protein, and 44% as carbohydrate; for further details of specific CAF diet components, see Crew et al. [28] .
Animals were maintained on these diets for 8 wk, during which time food intake was recorded each day in a subset of animals by weighing the CAF items remaining in the cage, and body weights were measured weekly in all animals. After the 8-wk feeding period, animals were mated overnight at proestrus (as determined by an estrous cycle monitor; EC40; Fine Science Tools). Pregnancy was confirmed by the presence of spermatozoa in a vaginal smear the following morning; this was designated as Day 1 of pregnancy. Animals were housed individually and maintained on their respective diets throughout gestation, and maternal caloric intake and body weights were measured daily.
Tissue Collection Procedure
Tissues were collected at four hourly intervals across each of Days 15-16 and 21-22 of pregnancy. The time of each collection was expressed relative to Zeitgeber time zero (ZT0), the time of lights-on (0700 h); samples were obtained at ZT1, ZT5, ZT9, ZT13, ZT17, and ZT21.
At each collection time, animals were anesthetized (n ¼ 7-8 per group) with isoflurane/nitrous oxide. Fetal-placental pairs were removed via cesarean section, and fetal and whole placental weights were recorded, after which placentas were dissected into labyrinth (LZ; the site of maternal-fetal exchange) and junctional (JZ) zones and weighed individually [29] . Because fetal sex is not externally distinguishable at Day 15, fetal tail tissue was collected for later sex determination by amplification of the Sry gene via RT-qPCR, as previously described [30] . Fetal sex was determined by anogenital distance at Day 21.
Maternal blood was taken from the descending aorta, and fetal trunk blood was collected at Day 21 via decapitation. Plasma was isolated by mixing samples with 10:1 (vol:vol) 0.6 M ethylene diamine tetraacetic acid (EDTA) and centrifuging at 13 000 3 g for 6 min. Plasma samples were then snap frozen in liquid nitrogen and stored at À808C until subsequent analysis.
Body Composition Analysis
Animals were euthanized following tissue collection, and a subset of maternal carcasses (n ¼ 23 CON, n ¼ 22 CAF) underwent body composition analysis by dual-energy x-ray absorptiometry (DEXA) using a GE Lunar Prodigy Series machine (GE Lunar). Body composition was assessed as total percentage adiposity, total lean mass, total fat mass, and bone mineral content using small animal software (Encore 2004, version 8.50.093; GE Lunar). Central adiposity and lean mass were also calculated by limiting scan analysis to the region between the superior iliac crests and the inferior sternum.
Plasma Steroid Measurement
Levels of corticosterone, 11-dehydrocorticosterone (11-DHC), progesterone, and testosterone were measured in maternal and Day 21 fetal plasma samples by liquid chromatography-tandem mass spectrometry (LC-MS/MS) with isotope dilution. This involved the addition of labeled compounds to correct for differences in steroid recovery and to account for signal variability during LCMS data acquisition. Samples (50 ll) were mixed with 50 ll of deuterated internal standards and incubated for 5 min at room temperature. Samples were then vortexed for 2 min with 1 ml of methyl tertiary butyl ether to extract steroids. Extracts were centrifuged and the supernatant removed and dried in a centrifugal vacuum evaporator for 30 min at 408C. Dried residue was resuspended in 70 ll of mobile phase (70% MeOH, 0.1% formic acid, and 29.9% H 2 O), then heated for 10 min at 508C, and 20 ll was injected onto an Agilent 6460 Triple Quadropole MS system coupled to two 1290 UPLC Series LC pumps (Agilent Technologies). The LC system was operated in 2-dimensional mode using two columns: an Agilent Poroshell 120 EC-C18 (2.1 mm 3 50 mm 3 2.7 lm; Agilent Technologies) and a Kinetex C18 (150 mm 3 3.0 mm 3 2.6 lm; Phenomenex). The mobile phase flow rate was 0.2 ml/min, and the column compartment temperature was 308C. The MS system was operated in positive ion multiple reaction-monitoring mode, and assay precision was evaluated by including EDTA plasma samples spiked with the relevant steroids (as quality controls). Interassay and intraassay coefficients of variation were 9.7% and 1.4%, respectively, for corticosterone, 17.5% and 3.2% for 11-DHC, 7.7% and 0.3% for progesterone, and 6.7% and 1.0% for testosterone.
Plasma Lipid Analysis
Total cholesterol (CHOL), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured enzymatically in maternal and Day 21 female fetal plasma samples, using reagents from Abbot Diagnostics (Abbott Laboratories). Assays were performed according to the manufacturer's instructions and were analyzed on an Architect c16000. The intraassay coefficients of variation were 0.9% for CHOL, 1.9% for TG, 2.0% for HDL-C, and 1.7% for LDL-C.
Statistical Analysis
All values are expressed as the mean 6 SEM, with each litter representing n ¼ 1. Statistical analysis was performed using GenStat 9.0 software. Maternal weight and food intake changes were assessed by repeated-measures ANOVA, whereas other comparisons among groups were made by ANOVA to account for variation due to diet, time of day, stage of pregnancy, and fetal sex. When significant interactions were observed, subsequent comparisons were performed by ANOVA or t-tests, as appropriate. When the F-test reached statistical significance (P , 0.05), specific group comparisons were made by least significant difference (LSD) tests.
Plasma steroid profiles were assessed for rhythmicity using nonlinear (cosinor) regression analysis in Genstat 9.0 software. This analysis generated the key rhythm characteristics (mesor, amplitude, and acrophase) for each steroid profile, and the influence of diet and stage of pregnancy on these characteristics was determined by two-way ANOVA (GraphPad Prism version 6.00). Daily profiles were considered rhythmic when their fit to the cosine function was significant (P , 0.05).
RESULTS
Caloric Consumption and Weight Gain in Cafeteria-Fed Animals
Cafeteria-fed animals exhibited a marked increase in caloric intake (P , 0.001) during the 8-wk prepregnancy feeding period (Table 1) , consistent with previously published data from a smaller cohort [28] . Accordingly, at Day 1 of pregnancy maternal weight was 25% higher in CAF compared with CON mothers (P , 0.001; Table 1 ). During pregnancy, CAF mothers continued to maintain greater caloric intake (P , 0.001), such that maternal weight was 25% and 21% higher in CAF mothers at Days 15 and 21, respectively (Table 1) .
Maternal Body Composition Analysis
CAF animals exhibited greater fat mass (Fig. 1A ) and higher total percentage body fat relative to CON at Day 15 (65% higher) and Day 21 (56% higher) of gestation (P , 0.001); similar patterns were observed for central adiposity (results not shown). Total lean mass was lower in CAF animals at both days of gestation (P , 0.001; Fig. 1B) . Consequently, the fat:lean mass ratio was markedly elevated in CAF animals on both days of gestation (Day 15: 2.6-fold higher; Day 21: 2.3-fold higher; P , 0.001; Fig. 1C ). CAF animals also exhibited increased bone mineral content (P , 0.001; Fig. 1D ) at both Day 15 (23%) and Day 21 (19%), and there was a marginal (6%) increase in bone mineral content from Day 15 to Day 21, regardless of diet (P ¼ 0.049).
Fertility Measures
CAF animals did not differ from CON in average time to copulation, fertility index (i.e., the proportion of positive smears leading to a pregnancy), or number of resorptions (data not shown). Surprisingly, CAF mothers had larger litter sizes than controls (CON, 13.4 6 0.3; CAF, 14.9 6 0.4; P , 0.001).
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Fetal and Placental Weights
At both days of pregnancy, fetal weight was reduced by the CAF diet, but it also varied with sex (male . female) and time of day (reflecting fetal growth across each 20-h period; Fig. 2 , A and D). Whole placental and LZ weights were also reduced by the CAF diet at both gestational ages. Interestingly, although whole placental and LZ growth was evident across Day 15, growth of these tissues had plateaued by Day 21. Despite this cessation of placental growth, substantial fetal growth still occurred across Day 21 (see Fig. 2 for data from females and Table 2 for all P values; three-way ANOVA). Accordingly, the fetal:LZ weight ratio increased by around 37% during Day 21 (from 11.3 6 0.2 at ZT1 to 15.3 6 0.4 at ZT21; P , 0.001, t-test). The JZ weight was reduced by the CAF diet at Day 21, and there was also a significant time of day effect in JZ growth (P ¼ 0.049), although this did not reflect a progressive increase across the day (Fig. 2F) .
Given the increased litter size in CAF animals, we also assessed whether total fetal, placental, JZ, and LZ weights per litter differed between the two diet groups. This analysis showed that total fetal weight was slightly higher in CAF mothers at Day 15 (9%; P ¼ 0.048 overall diet effect) but was unaffected by diet at Day 21 (data not shown). Total placental, JZ, and LZ weights were all unaffected by diet on either day of gestation (data not shown).
Rhythmic Profiles of Plasma Steroids
Corticosterone and 11-DHC. Cosinor analysis showed that corticosterone and 11-DHC were highly rhythmic in maternal plasma at each stage of gestation (Fig. 3, A, B, D , and E) and in male and female fetal plasma at Day 21 (Fig. 3, G , H, J, and K). In each case, however, the characteristics of these rhythms (mesor, amplitude, and acrophase) were unaffected by diet (Fig 3) . Interestingly, the fetal rhythm of corticosterone appeared to be phase advanced compared with the maternal rhythm; accordingly, there were significant differences between maternal and fetal corticosterone acrophase (;8 h different for both sexes; P , 0.05; t-tests). Consistent with these different daily profiles, fetal corticosterone levels at ZT1 were higher than corresponding maternal levels (P , 0.001; t- . In contrast, the acrophase of fetal 11-DHC profiles was similar to those for both corticosterone and 11-DHC in maternal plasma (Fig. 3) . The ratio of corticosterone to 11-DHC in maternal plasma was also unaffected by diet, but it did vary with time of day (P , 0.001; Fig. 3, C and F) . The fetal profile was quite different from that in the mother (Fig. 3F vs. Fig. 3, I and L) and exhibited a Diet 3 Time of Day interaction that was related to subtle differences in variation between the diet groups (Fig. 3, I and L).
Progesterone. Cosinor analysis revealed that progesterone profiles were rhythmic in CON animals but not in CAF mothers at Day 15 or in CAF male fetuses at Day 21. Therefore, progesterone data were analyzed by conventional ANOVA, which showed a maternal decline from Day 15 to Day 21 (P , 0.001), and marked time of day variation. The latter largely reflected a decline in progesterone during the dark hours in CON mothers (P , 0.001; Fig. 4, A and C) . Intriguingly, this nocturnal decline, which was clearly evident at both gestational ages, was absent in CAF mothers. A similar nocturnal progesterone reduction was observed in both male and female fetuses, but again, this was not observed in the CAF group (Fig. 4, E and G) . Consequently, comparison of progesterone concentrations between the ''light'' and ''dark'' photoperiods (light: ZT0-12; dark: ZT12-24) showed that CAF animals maintained higher levels exclusively in the dark period (P , 0.01; Fig. 4 , B, D, F, and H).
Corticosterone:progesterone ratio. Because progesterone can potentially act as an antiglucocorticoid [14] , the ratio of plasma corticosterone:progesterone may be important in the regulation of placental and fetal growth. Given the absence of the nocturnal decline in maternal and fetal progesterone in CAF animals, the corticosterone:progesterone ratio was compared between the light and dark periods. This showed no diet effects during either the light or dark at Day 15, but by Day 21 there was a marked reduction in the corticosterone:progesterone ratio in CAF animals during the dark hours in both the mother (CON, 19 6 5; CAF, 6 6 1; P , 0.01) and in male (CON, 103 6 16; CAF, 55 6 7; P , 0.01) and female (CON, 113 6 18; CAF, 56 6 6; P , 0.01) fetuses.
Testosterone. Although maternal plasma testosterone did not vary with diet overall, there was a significant Diet 3 Stage of Pregnancy interaction (P , 0.002). Separate analyses at each stage of pregnancy showed lower testosterone levels (8%; P ¼ 0.017; Fig. 5 ) in CAF mothers at Day 15, but higher levels at Day 21 (16%; P ¼ 0.014; Fig. 5 ). Although maternal plasma testosterone was not rhythmic at either day of gestation, significant cosinor rhythmicity was evident in CON male fetuses at Day 21 (Fig. 5) . In contrast, testosterone rhythmicity was lost in male fetuses of CAF-fed mothers, which did not show the morning (ZT1) elevation evident in CON (P ¼ 0.008). Testosterone levels in female fetal plasma fell below the detection threshold (,0.05 ng/ml) in both dietary groups (data not shown).
Plasma Lipid Profiles
All maternal lipids varied overall with diet (P , 0.05) and increased with advancing gestation (P , 0.001). Lipid analytes were largely arrhythmic (by cosinor analysis) and did not exhibit overall time of day variation, but each exhibited Diet 3 Time of Day or Diet 3 Photoperiod interactions by ANOVA at one or both stages of pregnancy (P , 0.05). This analysis revealed that the CAF diet reduced maternal CHOL levels during the light period at Day 15 (13% lower; P , 0.001; Fig.  6A ), but it increased levels at ZT17 on Day 21 (P , 0.001; Fig.  6E ). The CAF diet also increased TG levels at both gestational days, but for Day 21 this was evident only during the dark period (P ¼ 0.02; Fig. 6 , B and F). In contrast, the CAF diet reduced maternal HDL-C on both days, but again, this effect was restricted to the dark period for Day 21 (Fig. 6, C and G) . Finally, maternal LDL-C levels were increased by the CAF diet only during in the dark hours at both gestational days (each P , 0.01; 
DISCUSSION
This study demonstrates that obesity induced by cafeteria feeding disrupts maternal and fetal rhythmic profiles of progesterone during pregnancy, preventing the nocturnal decline in progesterone in both compartments. Obesity also altered maternal and fetal testosterone profiles but had minimal effects on the HPA axis. These obesity-induced changes in steroid hormone levels occurred in conjunction with maternal and fetal hyperlipidemia, and a reduction in individual, but not total, fetal and placental weights over the final third of gestation.
The CAF-induced increase in maternal progesterone at both days of pregnancy supports and extends other recent studies in rodents, in which elevated progesterone levels were observed in high-fat (HF)-fed mothers at both mid [21] and late [20] gestation. Importantly, these studies did not take into account 
RHYTHMIC STEROID PROFILES IN OBESE PREGNANCY
the possible circadian influences on progesterone secretion; our results demonstrate that circulating progesterone in control mothers and fetuses exhibited pronounced rhythmic variation characterized by a marked nocturnal decline, and that this nocturnal decline was prevented by maternal obesity. To our knowledge, these data are the first to demonstrate rhythmic variation of progesterone in rat pregnancy (in either the mother or fetus), and are comparable to our recent observations in the mouse [25] . Rhythmic profiles of progesterone have been reported for both mother and fetus in nonhuman primates, and these have been linked to circadian variation in fetal adrenal steroid production [24] . In contrast, rhythmic progesterone profiles observed in the present study and in mouse pregnancy [25] likely reflect circadian variation in luteal progesterone secretion. The corpus luteum is the major source of progesterone in rodent pregnancy and also has a functional clock gene network [31, 32] . Thus, loss of the nocturnal decline in progesterone in CAF mothers may be mediated by disruption of this luteal clock, because previous studies show marked changes to clock gene expression in the metabolic tissues of obese rodents [26, 27] , and clock genes appear to regulate ovarian progesterone synthesis [33, 34] . CREW ET AL.
Interestingly, maternal LDL-C profiles appeared to broadly parallel those of progesterone. Given LDL-C is a precursor for progesterone synthesis [35] , elevated LDL-C in CAF mothers may contribute to the loss of the nocturnal progesterone decline. There was no such similarity between fetal LDL-C and progesterone profiles, consistent with fetal progesterone being derived largely from luteal synthesis [36] . The maintenance of elevated nocturnal progesterone in obese mothers may also be mediated via metabolic hormone disturbances. For example, insulin promotes steroidogenesis in granulosa and thecal cells [37] , and HF feeding in nonpregnant rats increases circulating progesterone in conjunction with hyperinsulinemia and altered insulin signaling in the ovary [38] . Similarly, leptin has been shown to stimulate progesterone production by luteal cells both alone [39] and in the presence of IGF-1 [40] , whereas adiponectin also regulates ovarian steroidogenesis, including luteal progesterone synthesis [41] . Further studies are required to determine whether increased insulin, leptin, or other adipokines contribute to the CAF-induced elevation in maternal and fetal progesterone during pregnancy. It will also be of interest to explore the extent to which progesterone is affected by obesity in human pregnancy; in contrast to the rodent response, recent human studies suggest maternal progesterone is reduced in obese pregnancy [16, 42] , possibly due in part to species differences in the major source of progesterone (luteal in rodents, placental in humans).
Higher progesterone levels observed in obese pregnancy could potentially exert both positive and negative effects on pregnancy outcome. For example, elevated progesterone would be expected to support placental and fetal growth, possibly by countering the growth inhibitory effects of glucocorticoids [14] . Even though maternal corticosterone levels were not affected by obesity in the current study, the corticosterone: progesterone ratio in CON mothers was substantially higher in 
the dark hours at Day 21. In contrast, the absence of the nocturnal progesterone decline in obese mothers could potentially disrupt the timing of parturition, which is initiated in part via reduced progesterone signaling [43] . Indeed, human data clearly show a diurnal pattern in the timing of labor [44, 45] , but further studies are required to determine whether this is affected by maternal obesity.
Contrary to our hypothesis, corticosterone and 11-DHC rhythms were largely unaffected by obesity in both maternal and fetal compartments. Previous rodent studies using only a single time point show either unchanged [46] or increased maternal corticosterone in obese pregnancy [18, 19] . Mixed responses to obesity have also been observed in human pregnancy, with reports of both decreased morning cortisol levels [16] and increased evening levels [17] , suggestive of some degree of circadian disruption. Our data also provide the first account of the full rhythmic profiles of fetal corticosterone and 11-DHC, but these were largely unaffected by maternal obesity.
Comparison of glucocorticoid rhythms in the mother and fetus showed some unexpected asynchrony, possibly related to circadian shifts in maternal and fetal corticosterone production rates. Thus, although maternal and fetal 11-DHC rhythms appeared synchronous at Day 21 (with peaks at around the time of lights-off), the fetal corticosterone peak occurred around 8 h earlier than that in the mother. Indeed, fetal corticosterone levels exceeded maternal levels at ZT1, as previously reported for this stage of gestation [47] . This suggests that fetal production of corticosterone at term is elevated at stages of the daily cycle when maternal levels are low. It seems likely, therefore, that the fetus contributes to maternal corticosterone in late gestation, and that this contribution varies across the day. Although the placental glucocorticoid barrier impedes transfer of glucocorticoids between maternal and fetal compartments, this barrier is reduced to relatively low levels near term [48] . Shifts in the rhythmic fetal production of corticosterone may also account for the observed maternal-fetal differences in the corticosterone:11-DHC ratio. Confirmation of this, however, would require isotopic tracer studies conducted at different times across the day.
Previous studies show that elevated maternal testosterone in late gestation reduces birth weight [49, 50] , an effect possibly mediated by reduced nutrient transfer capacity in the placenta [11] . Our data show that obesity slightly reduced maternal testosterone at Day 15 but resulted in increased levels by Day 21. In contrast, CAF male fetal testosterone levels were lower early on Day 21, after which they were similar to controls. Although several rodent models show that male offspring born to obese mothers have reduced testosterone and lower sperm counts [51, 52] , to our knowledge this is the first evidence for obesity-induced effects on testosterone in fetal life. Male fetal testosterone levels normally exhibit a surge at Day 19 of pregnancy, fall briefly at Day 21, then peak again shortly after birth, coincident with key testicular development in rats [53] . Our data suggest that maternal obesity may suppress this normal pattern of testosterone in fetal life, potentially mediating adverse programming effects on male fertility. CAF feeding also induced hyperlipidemia (i.e., elevated CHOL, TG, and LDL-C) and reduced HDL-C levels in maternal and fetal plasma. To our knowledge, these data provide the first account of rhythmic circulating lipid profiles during obese pregnancy. Most notably, by Day 21 CAF mothers showed only nocturnal hyperlipidemia, an effect likely associated with the nocturnal feeding patterns of laboratory rodents. Moreover, both intestinal lipid absorption [54] and mobilization of lipids from adipose tissue display circadian rhythmicity [55] , and so CAF mothers could potentially experience disruptions to the circadian control of digestive and/or adipose tissue function. Human studies show that although obese women are hyperlipidemic early in gestation, this effect is less pronounced later in gestation; indeed, some studies show that obese pregnant women have lower circulating lipids compared with their normal-weight counterparts [56, 57] . Given our observation of nocturnal hyperlipidemia in obese dams near term, further analysis of circadian variation in the lipid status of obese pregnant women would seem warranted.
We also noted growth restriction of individual placentas and fetuses in CAF animals, consistent with several other rodent obesity models [46, [58] [59] [60] . Obesity may influence fetal growth by altering various aspects of placental function, such as nutrient transport or vascular development [61] . Although further studies are necessary to determine whether placental function is altered by the CAF diet, the increased litter size in the CAF group likely contributes to the lower fetal and placental weights reported in our model, because there was no difference in total fetal or placental weight per litter between dietary groups. Given that obesity is generally associated with reduced fertility in both humans and rodents [62, 63] , this increased litter size was unexpected. It most likely reflects a higher ovulation rate in CAF animals, because the number of resorptions did not differ between groups. Unfortunately, corpora lutea were not collected in these experiments, so further studies are needed to confirm this suggested increase in ovulation rate. Importantly, compromised placental function [64] and programmed health complications in offspring [65, 66] can occur without overt changes to fetal growth. Moreover, larger litter size has been associated with adverse neurological and metabolic programming outcomes in rats, likely due to reduced nutrition access and consequent disruptions to postnatal growth trajectories [67] . This suggests that offspring of CAF mothers may experience altered postnatal outcomes.
This study also provides an interesting insight into the daily patterns of fetal and placental growth at the two stages of pregnancy. Across the sampling period at Day 15, rapid relative growth was evident for both the fetus (weight increase of 64% during 20 h) and the placenta (60% increase), with the latter attributable almost exclusively to LZ growth (72% increase). By Day 21, fetal growth continued at a rapid absolute rate (increase of approximately 1.2 g per fetus during 20 h), despite the effective cessation of placental growth. This capacity for fetal weight to increase by more than 30% in 20 h without any change in placental weight highlights the remarkable increase in placental efficiency that occurs at this late stage of pregnancy.
In conclusion, this study shows that maternal obesity disrupts the rhythmic profiles of progesterone in both the maternal and fetal compartments, and increases maternal testosterone levels while suppressing male fetal testosterone near term. These obesity-induced changes in the daily profiles of progesterone and testosterone occurred in conjunction with maternal and fetal hyperlipidemia, but without any overt effects on the maternal or fetal HPA axes.
